Abstract

Historic data and baseline surveys showed schistosomiasis as highly/moderately endemic in 7 of 14 districts in Sierra Leone, justifying annual/biennial mass drug administration (MDA) with praziquantel. MDA commenced in 2009 and reported treatment coverage had been above the World Health Organization recommended 75% of target population. Assessment in 2012 showed significant reduction in infection. In 2016, another national school-based survey was conducted to evaluate the progress. Two schools from each category (high, moderate or low) of endemic communities in each MDA district and five schools in non-MDA districts were selected. Fifty children (25 boys and 25 girls) aged 9–14 years were randomly selected per school. Parasitological examination of 1,980 stool and 1,382 urine samples were conducted. Overall Schistosoma mansoni prevalence in the seven MDA districts decreased to 20.4% (95% CI: 18.7–22.3%) in 2016 from 42.2% (95% CI: 39.8–44.5%) at baseline (p < 0.0001). Mean overall S. mansoni intensity of infection reduced to 52.8 epg (95% CI: 43.2–62.4 epg) in 2016 from 100.5 epg (95% CI: 88.7–112.3 epg) at baseline (p < 0.001). The prevalence of Schistosoma haematobium in the five MDA districts that had baseline prevalence data decreased to 2.2% (95% CI: 1.5–3.1%) in 2016 from 18.3% (95% CI: 16.3–20.5%) at baseline (p < 0.0001). Mean overall intensity of infection increased to 1.12 e/10 ml (95% CI: 0.55–0.1.70 e/10 ml) in 2016 compared to 0.47 e/10 ml (95% CI: 0.16–0.78 e/10 ml) in 2012 (p < 0.05) (no baseline data). No district was highly endemic in 2016 compared to three at baseline and there was no significant difference in prevalence or intensity of infection by sex for both species. This survey illustrated the significant progress made in controlling schistosomiasis in Sierra Leone. The fact that prevalence and intensity of infection showed an increase from the 2010 level suggested a detrimental effect of missing MDA due to the Ebola toward schistosomiasis control. The national program needs to continue the treatment and adopt a comprehensive approach including water, hygiene, and sanitation measures to achieve control and elimination of schistosomiasis.

Highlights

  • Schistosomiasis was estimated to be the third leading cause of Disability Adjusted Life Years among neglected tropical diseases (NTDs) worldwide [1] and second after malaria in Sub-Saharan Africa accounting for 200,000 deaths annually [2,3,4]

  • This paper presents the results and discusses the revised national schistosomiasis control strategy

  • Treatments were recorded on tally sheets which were summarized at the local health facility, sent to the district NTD focal point for compilation and reporting to the national Neglected Tropical Disease Program (NTDP)

Read more

Summary

Introduction

Schistosomiasis was estimated to be the third leading cause of Disability Adjusted Life Years among neglected tropical diseases (NTDs) worldwide [1] and second after malaria in Sub-Saharan Africa accounting for 200,000 deaths annually [2,3,4]. The two main human species in Africa are Schistosoma mansoni (causing intestinal schistosomiasis) and Schistosoma haematobium (causing urogenital schistosomiasis) that are transmitted via intermediate host snails Biomphalaria sp. Chronic intestinal schistosomiasis is manifested by hepatosplenomegaly [8], while urogenital schistosomiasis is associated with urinary obstructions, bladder cancer [9], and heightens the spread of HIV and its progress to AIDS [10, 11]. Both can cause anemia due to inflammation, blood loss, and malnutrition and reduce life expectancy [12,13,14,15]. To be effective each MDA should reach at least 75% of those at risk [22, 23]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call